ATC Group: D06AX04 Neomycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D06AX04 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D06 Antibiotics and chemotherapeutics for dermatological use
3 D06A Antibiotics for topical use
4 D06AX Other antibiotics for topical use
5 D06AX04 Neomycin

Active ingredients in D06AX04

Active Ingredient Description
Neomycin

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

Related product monographs

Title Information Source Document Type  
NIVEMYCIN Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Albania (AL)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Malta (MT)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.